Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53

Cancer Research

Volumn 58, Issue 6, 1998, Pages 1090-1094

  Cote, Richard J ^a   Dunn, Matthew D ^a   Chatterjee, Sunanda J ^a   Stein, John P ^a   Shi, Shan Rong ^a   Tran, Quoc Chau ^b   Hu, Shi Xue ^c   Xu, Hong Ji ^c   Groshen, Susan ^b   Taylor, Clive R ^a   Skinner, Donald G ^b   Benedict, William F ^c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; RETINOBLASTOMA PROTEIN;

ARTICLE; BLADDER CARCINOMA; CANCER RECURRENCE; CANCER SURVIVAL; CELL CYCLE; CONTROLLED STUDY; CYSTECTOMY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

CARCINOMA, TRANSITIONAL CELL; DISEASE-FREE SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; GENES, RETINOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; RETINOBLASTOMA PROTEIN; SURVIVAL ANALYSIS; URINARY BLADDER NEOPLASMS;

EID: 0032521376     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Fearon, E. R., and Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell, 61: 759-767, 1990.
2. Esrig, D., Elmajian, D., Groshen, S., Freeman, J. A., Stein, J. P., Chen, S-C., Nichols, P. W., Skinner, D. G., Jones, P. A., and Cote, R. J. Accumulation of nuclear p53 and tumor progression in bladder cancer. N. Engl. J. Med., 331: 1259-1264, 1994.
3. Sarkis, A. S., Dalbagni, G., Cordon-Cardo, C., Zhang, Z. F., Sheinfeld, J., Fair, W. R., Herr, H. W., and Reuter, V. E. Nuclear overexpression of p53 protein in transitional carcinoma: a marker for disease progression. J. Natl. Cancer Inst., 85: 53-59, 1993.
4. Cordon-Cardo, C., Wartinger, D., Petrylak, D., Dalbagni, G., Fair, W. R., Fuks, Z., and Reuter, V. E. Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer. J. Natl. Cancer Inst., 84: 1251-1256, 1992.
5. Logothetis, C. J., Xu, H. J., Ro, J. Y., Hu, S. X., Sahin, A., Ordonez, N., and Benedict, W. F. Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer. J. Natl. Cancer Inst., 84: 1256-1261, 1992.
6. Xu. H. J., Cairns, P., Hu, S-X., Knowles, M. A., and Benedict, W. F. Loss of Rb protein expression in primary bladder cancer correlates with loss of heterozygosity at the Rb locus and tumor progression. Int. J. Cancer, 53: 781-784, 1993.
7. Cordon-Cardo, C. Mutation of cell cycle regulators: biological and clinical implications for human neoplasia. Am. J. Pathol., 147: 545-560, 1995.
8. Williams, B. O., Remington, L., Albert, D. M., Mukai, S., Bronson, R. T., and Jacks, T. Cooperative tumorigenic effects of germline mutations in Rb and p53. Nat. Genet., 7: 480-484, 1994.
9. Esrig, D., Spruck, C. H., III, Nichols, P. W., Chaiwun, B., Steven, K., Groshen, S., Chen, S-C., Skinner, D. G., Jones, P. A., and Cote, R. C. p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Am. J. Pathol., 143: 1389-1397, 1993.
10. Hermanek, P., and Sabin, L. H. (eds.). TNM Classification of Malignant Tumors, 4th ed., pp. 133-1434. New York: Springer-Verlag, 1987.
11. Shi, S-R., Cote, R. J., Yang, C., Chen, Xu, H-J., Benedict, W. F., and Taylor, C. R., Development of an optimal test battery approach exemplified with reference to the staining of retinoblastoma protein (pRb) in formalin-fixed paraffin sections. J. Pathol., 179: 347-352, 1996.
12. Feinberg, S. E. The Analysis of Cross-Classified Categorical Data, pp. 9-86. Cambridge, MA: MIT Press, 1977.
13. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
14. Miller, R. G., Jr. Survival Analysis, pp. 44-102. New York: John Wiley, 1981.
15. Knudsen, E. S., and Wang, J. Y. J. Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites. J. Biol. Chem., 271: 8313-8320, 1996.
16. Johnson, D., Schwarz, J. K., Cress, W. D., and Nevins, J. R. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature (Lond.), 365: 349-352, 1993.
17. Kornblau, S. M., Xu, H-J., Zhang, W., Hu, S-X., Beran, M., Smith, T. L., Hester, J., Estey, E., Benedict, W. F., and Deisseroth, A. B. Levels of retinoblastoma protein expression in newly diagnosed acute myelogenous leukemia. Blood, 84: 256-261, 1994.
18. 1 cyclin-dependent kinases. Genes Dev., 9: 1149-1163, 1995.
19. 1 cyclin-cdk protein kinase activity, is related to p21. Cell, 78: 67-74, 1994.
20. Cordon-Cardo, C., Zhang, Z-F., Dalbagni, G., Drobnjak, M., Charytonowicz, E., Hu, S. X., Xu, H. J., Reuter, V. E., and Benedict, W. F. Cooperative effects of p53 and pRb alterations in primary superficial bladder tumors. Cancer Res., 57: 1217-1221, 1997.